ArticleBlood advances2020
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide.
Scott R Solomon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it